89
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Serum urate goal attainment and associated factors in Chinese gout patients

, , ORCID Icon, , , , , & show all
Pages 931-939 | Received 19 Mar 2019, Accepted 21 Nov 2019, Published online: 23 Dec 2019
 

ABSTRACT

We conducted a cross-sectional study with 350 gout patients to investigate serum urate acid (sUA) goal attainment (sUA < 360 μmol/L) and associated factors in Chinese gout patients in the Affiliated Hospital of Nantong University from August 2015 to September 2017. Descriptive statistics, health assessment questionnaire, global visual analog scale for general health and Gout Knowledge Questionnaire were calculated comparing patients at sUA goal or not at sUA goal. Univariate analysis and logistic regression models were applied to analyze data. The proportion of urate-lowering therapy (ULT) use was 61.2% (211/350). The mean ± standard deviation sUA of the participants was 475.07 ± 121.53 μmol/L. Only 17.4% of gout patients attain the serum urate goal, which also means 289(82.6%) patients cannot keep their sUA below the target of 360 μmol/L. The factors associated with sUA goal attainment including age, education level and ULT use. Among these, age, waist hip ratio, ULT, family history of cardiovascular disease was the predictor of sUA goal attainment. In conclusion, more than 80% of gout patients did not achieve sUA goal. Younger and fatter patients were more difficult to control the serum urate level.

View correction statement:
Correction

Data availability

All relevant data are within the manuscript and its Supporting Information files.

Disclosure statement

No potential conflict of interest was reported by the authors.

Ethics statement

This survey was approved by the Ethics Committee of Affiliated Hospital of Nantong University, and informed written consent from each participant obtained. The Clinical Trial Registration number for this study is 2017-K003.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.